Abstract 2532: Pediatric osteosarcoma patients are taller than average from birth to age twelve: a report from the Children's Oncology Group. AACR Annual Meeting

Logan G Spector, Kathryn Ritter, Ellen Demerath, Charles Sklar, Julie A. Ross, Mark Krailo, Rajaram Nagarajan, David Malkin, Tracy Bergemann, Sharon Savage, William Johnson

Research output: Contribution to conferencePaper

Abstract

Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Osteosarcoma (OS) is the most common form of bone cancer in children and displays a peak incidence that coincides with the pubertal growth spurt. Consequently a number of studies have investigated whether cases are taller at diagnosis than the general pediatric population; a recent analysis which pooled seven such studies found that cases were disproportionately in the 51st-89th and especially the >90th percentiles of height-for-age (HFA). However, no study to our knowledge has examined whether OS patients exhibit greater HFA at earlier ages. During 2008-2010 we enrolled 290 OS cases
Original languageEnglish (US)
StatePublished - 2013

Fingerprint Dive into the research topics of 'Abstract 2532: Pediatric osteosarcoma patients are taller than average from birth to age twelve: a report from the Children's Oncology Group. AACR Annual Meeting'. Together they form a unique fingerprint.

Cite this